Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

The following is a summary of “Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention,” published in the ...

Patients with osteoarthritis, but not immune-related arthritis, demonstrate increased odds for developing overactive bladder ...

IXIFI is a biosimilar to Remicade (infliximab). It was approved by Health Canada in December 2021 for all eligible indications of the reference product.

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

At the recent SEC meeting for analgesics and rheumatology held on February 25, 2025, the expert panel reviewed the ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...

Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.